Debra has more than 25 years experience in the health care industry, primarily focused on women's and children's health. She has led Novasys Medical as President and CEO since 2001, from the company's early stages of animal studies, human clinicals and FDA clearance to the commercialization of the Renessa procedure. She has funded the company's progress through three rounds of financing with leading medical device venture investors. Based on her fundraising success, she was asked to author a chapter entitled "The Fundraising Process: A CEO's Perspective" in Inside the Minds: Raising Capital for Health Care Companies. Prior to Novasys, Debra was Vice President and General Manager of Tyco Healthcare, Nellcor Division, for more than 10 years leading the entrepreneurial Perinatal business. She provided leadership and vision for the development and commercialization of the division's key product, a breakthrough technology for non-invasive oxygen monitoring of the fetus during labor and delivery. Debra commenced her career as a Respiratory Therapist and later was Assistant Director for Labor and Delivery, Pediatrics and Neonatal Intensive Care at Loyola Medical Center in Chicago, Il. She holds an A.S. in Respiratory Care (CRTT, RRT), a B.S. and an MBA. Debra is a leader in numerous professional organizations, including as a member of the Advisory Board to the Professional Women's Healthcare Alliance. Her work at Novasys has been the subject of both Stanford University and Harvard Business School Cases and she is a frequent speaker on FDA and Reimbursement topics.

Kevin joined Novasys Medical as Interim Chief Financial Officer in September 2009. He possesses an outstanding record of achievement with companies ranging from publicly traded to late stage pre-IPO and start-ups. Kevin is a strategic thinker with excellent analytical and communication skills. Prior to Novasys, he served as Chief Financial Officer for five other medical device/biomedical companies – HX Diagnostics, ZONARE Medical Systems, R2 Technology, Virologic and Athena Neurosciences. His skill set and accomplishments include significant fund raising expertise having raised over $200 million through public and private equity financings, subordinated debt and convertible structures and significant M&A, product acquisition and licensing transactions. In addition, Kevin is well-versed in high growth environments with revenues ramping from zero to $70 million in under five years while attaining profitability and has an extensive background in implementation of financial systems and process improvements to accommodate needs of high growth, dynamic environments. He is operationally focused with developing strong teams within Finance, Information Technology and Human Resource organizations. Earlier in his career Kevin held management roles at Network Equipment Technologies and the international accounting firm of KPMG Peat Marwick. He holds a Bachelors degree in Business Administration from the University of California, Berkeley, where he graduated summa cum laude and was elected to Phi Beta Kappa.